Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
Author:
Funder
National Research Foundation of Korea
Publisher
Frontiers Media SA
Subject
Endocrinology, Diabetes and Metabolism
Reference93 articles.
1. Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back;Ahn;Theranostics,2012
2. False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer;Oh;Am J Nucl Med Mol Imaging,2012
3. Nuclear medicine in the era of precision medicine;Ahn;Nucl Med Mol Imaging,2017
4. Difference of clinical and radiological characteristics according to radioiodine avidity in pulmonary metastases of differentiated thyroid cancer;Kim;Nucl Med Mol Imaging,2014
5. Personalized medicine based on theranostic radioiodine molecular imaging for differentiated thyroid cancer;Ahn;Biomed Res Int,2016
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeted Therapy in Thyroid Cancer;Indian Journal of Endocrine Surgery and Research;2024-06-17
2. Efficacy of Empirical 131I Radioiodine Therapy in Well-Differentiated Thyroid Carcinoma Patients With Thyroglobulin-Elevated Negative Iodine Scintigraphy Syndrome;Clinical Nuclear Medicine;2024-05-31
3. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma;Frontiers in Endocrinology;2024-04-15
4. Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid Cancer;Thyroid®;2024-01-18
5. CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway;Functional & Integrative Genomics;2024-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3